Sunday 18 October 2026
Export SEER’s income statement to Excel — free account
Seer, Inc.
SEER Healthcare Biotechnology
Seer, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.6 million, up 17.0% from fiscal 2024. In the quarter to June 2026, revenue fell 23.4%, EPS grew 6.06% and free cash flow grew 36.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
2.03
0.01
−0.49%
Follow SEER
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 4 | 4 |
| (25.74%) | (25.08%) | (25.52%) | (26.45%) | ||
| (22.93%) | (22.21%) | (22.76%) | (23.47%) | ||
ROIC |
(72.42%) | (66.40%) | (62.26%) | (60.78%) | |
Return on Tangible Assets |
(36.94%) | (36.69%) | (38.14%) | (40.70%) | |
Average Days of Receivables |
114.94 | 131.05 | 102.43 | 88.11 | |
Free Cash Flow per Share |
(0.80) | (0.79) | (0.88) | (0.80) | |
Free Cash Flow |
(45.08) | (45.60) | (49.53) | (43.98) | |
Capital Expenditures |
0.02 | (1.15) | (1.07) | (0.60) | |
| Other line items | |||||
Cash ROIC |
(9.57%) | (10.24%) | (12.14%) | (11.62%) | |
Accounts Receivable Turnover |
2.82 | 2.72 | 3.16 | 3.11 | |
Accounts Payable Turnover |
3.23 | 1.59 | 2.24 | 2.55 | |
Inventory Turnover |
1.07 | 1.07 | 1.03 | 0.98 | |
Average Days of Payables |
192.72 | 252.44 | 117.15 | 155.16 | |
Days of Inventory on Hand |
367.53 | 350.69 | 379.03 | 376.14 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
285.47% | 264.65% | 272.52% | 264.15% | |
Selling, General and Administrative Expense of Revenue |
278.75% | 256.86% | 267.53% | 281.74% | |
Share Based Compensation of Revenue |
113.37% | 92.98% | 84.91% | 74.35% | |
Operating CF/Net income |
0.57 | 0.60 | 0.69 | 0.64 | |
Depreciation/Fixed assets |
0.53 | 0.49 | 0.51 | 0.56 | |
Capex/Depreciation |
0.00 | (0.16) | (0.16) | (0.09) | |
Revenue per Share |
0.29 | 0.29 | 0.27 | 0.26 | |
Operating CF per Share |
(0.80) | (0.77) | (0.87) | (0.79) | |
Capex per Share |
0.00 | (0.02) | (0.02) | (0.01) | |
Capex to Sales |
0.00 | 0.07 | 0.07 | 0.04 |
Columns are period end dates